● Recruiting

Impact of Steatotic Liver Disease Associated With Metabolic Dysfunction (MASLD) on Frailty, Cognition, and Quality of Life. A Gender-sensitive Approach Towards a Comprehensive and Equitable Perspective.

Condition: Steatosis of Liver · Sponsor: Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau

PhaseN/A

Planned participants140

Who can joinAll sexes, 20 Years to 80 Years

Healthy volunteersNo

About this study

The goal of this observational study is to determine the differences in the prevalence, characteristics and evolution of frailty between men and women diagnosed with MASLD, and to establish its relationship with clinical, functional, hormonal and social parameters.

This description comes directly from the study's public registry record.

Talk to the study team

Eva Román, Digestive Pathology Nurse · 0034630818580 · ERoman@santpau.cat

German Soriano, Digestive Pathology MD · gsoriano@santpau.cat

Always discuss trial participation with your own doctor first.

Locations (2)

Hospital de la Santa Creu i Sant Pau	Barcelona, Barcelona, Spain	Not Yet Recruiting
Hospital de la Santa Creu i Sant Pau	Barcelona, Barcelona, Spain	Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07652892